MAN1A2
Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB
Also known as: MA1A2_HUMAN, MAN1B
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O60476
- Gene
- MAN1A2
- Ensembl
- ENSG00000198162
- Chromosome
- 1
- Canonical length
- 641 aa
- Protein class
- Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Golgi apparatus
OverviewNCBI Gene
Alpha-mannosidases function at different stages of N-glycan maturation in mammalian cells. See MAN2A1 (MIM 154582) for general information.[supplied by OMIM, Mar 2008]
Canonical amino-acid sequenceUniProt
641 residues, UniProt reviewed canonical sequence.
>O60476|MAN1A2
1 MTTPALLPLS GRRIPPLNLG PPSFPHHRAT LRLSEKFILL LILSAFITLC FGAFFFLPDS
61 SKHKRFDLGL EDVLIPHVDA GKGAKNPGVF LIHGPDEHRH REEEERLRNK IRADHEKALE
121 EAKEKLRKSR EEIRAEIQTE KNKVVQEMKI KENKPLPPVP IPNLVGIRGG DPEDNDIREK
181 REKIKEMMKH AWDNYRTYGW GHNELRPIAR KGHSPNIFGS SQMGATIVDA LDTLYIMGLH
241 DEFLDGQRWI EDNLDFSVNS EVSVFEVNIR FIGGLLAAYY LSGEEIFKIK AVQLAEKLLP
301 AFNTPTGIPW AMVNLKSGVG RNWGWASAGS SILAEFGTLH MEFIHLSYLT GDLTYYKKVM
361 HIRKLLQKMD RPNGLYPNYL NPRTGRWGQY HTSVGGLGDS FYEYLLKAWL MSDKTDHEAR
421 KMYDDAIEAI EKHLIKKSRG GLTFIGEWKN GHLEKKMGHL ACFAGGMFAL GADGSRADKA
481 GHYLELGAEI ARTCHESYDR TALKLGPESF KFDGAVEAVA VRQAEKYYIL RPEVIETYWY
541 LWRFTHDPRY RQWGWEAALA IEKYCRVNGG FSGVKDVYSS TPTHDDVQQS FFLAETLKYL
601 YLLFSGDDLL PLDHWVFNTE AHPLPVLHLA NTTLSGNPAV RLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MAN1A2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 34 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 34 nTPM
- parathyroid gland: 31 nTPM
- thyroid gland: 24 nTPM
- placenta: 20 nTPM
- liver: 20 nTPM
- retina: 17 nTPM
Single-cell type
- syncytiotrophoblasts: 913 nCPM
- extravillous trophoblasts: 676 nCPM
- choroid plexus epithelial cells: 368 nCPM
- plasma cells: 322 nCPM
- pancreatic acinar cells: 317 nCPM
- corticotrophs: 286 nCPM
Immune cell
- T-reg: 6.3 nTPM
- NK-cell: 3.9 nTPM
- MAIT T-cell: 3.6 nTPM
- gdT-cell: 3 nTPM
- naive CD8 T-cell: 2.9 nTPM
- plasmacytoid DC: 2.7 nTPM
Brain region
- basal ganglia: 58 nTPM
- cerebral cortex: 56 nTPM
- white matter: 52 nTPM
- cerebellum: 51 nTPM
- hypothalamus: 51 nTPM
- choroid plexus: 50 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.24
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.56
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- carbohydrate metabolic process
- ERAD pathway
- Golgi apparatus N-glycan mannose trimming
- lung alveolus development
- N-glycan processing
- respiratory gaseous exchange by respiratory system
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MAN1A2 as an antibody target. Whether an autoantibody or antibody against MAN1A2 could matter depends on whether native MAN1A2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MAN1A2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MAN1A2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...